Who Owns INMED PHARMACEUTICALS INC COM NEW (INM)? -- Institutional Holders (2026-06-30)

22 institutions reported holding $4.2M of INMED PHARMACEUTICALS INC COM NEW (INM) in SEC 13F filings for 2026-06-30. Largest institutional holders: ADAR1 Capital Management, LLC ($1.2M), Vivo Capital, LLC ($1.2M), Squadron Capital Management LLC ($503,750), Ikarian Capital, LLC ($379,788), Ursa Fund Management, LLC ($194,990). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1ADAR1 Capital Management, LLC$1.2M800,000New
2Vivo Capital, LLC$1.2M798,377New
3Squadron Capital Management LLC$503,750325,000New
4Ikarian Capital, LLC$379,788245,025New
5Ursa Fund Management, LLC$194,990125,800New
6SUVRETTA CAPITAL MANAGEMENT, LLC$155,000100,000New
7BOOTHBAY FUND MANAGEMENT, LLC$115,07874,244New
8SABBY MANAGEMENT, LLC$69,70444,970Trimmed
9JANE STREET GROUP, LLC$66,77143,078New
10VR ADVISER, LLC$50,66232,685New
11CITADEL ADVISORS LLC$40,43026,084Trimmed
12SEVEN GRAND MANAGERS, LLC$38,75025,000New
13Scientech Research LLC$23,96515,461New
14Crestwood Advisors Group, LLC$23,09514,900New
15TWO SIGMA SECURITIES, LLC$16,96510,945Trimmed
16Stratos Wealth Partners, LTD.$16,67810,760New
17Private Wealth Management Group, LLC$7,7505,000Hold
18Banque Cantonale Vaudoise$1,0006Hold
19SBI Securities Co., Ltd.$465300Hold
20Federation des caisses Desjardins du Quebec$42Hold
21Virtu Financial LLC$00Exited
22UBS Group AG$00Exited

Source: SEC Form 13F filings · as of 2026-06-30